ATLANTA, Feb. 06, 2019 (GLOBE NEWSWIRE) -- TendoNova™ Corporation was one of just five companies chosen to present on the national stage as a finalist for the 2019 NFL’s “1st and Future” competition on Super Bowl weekend.
TendoNova beat out more than 100 applicants from across the globe to land a top-five finalist spot. The company’s innovative medical device targets chronic tendon pain such as tennis elbow and plantar fasciitis.
"It was a tremendous honor to be named a finalist among so many other outstanding companies and to participate in the NFL ‘1st and Future’ competition,” said Roy Wallen, CEO of TendoNova. “Support and mentorship from organizations like the NFL and ATDC are critical to our industry and help make these groundbreaking solutions a reality.”
The TendoNova team pitched in front of NFL players, coaches, owners, physicians, investors and viewers across the country. Judges included:
- Geoff Collins, Head Coach, Georgia Tech Football
- Leigh Ann Curl, MD, Head Team Orthopedic Surgeon, Baltimore Ravens, and President, NFL Physicians Society
- Sarath Degala, Vice President, BIP Capital
- Victor Gao, Chief Marketing Officer, Arrow Electronics, Inc.
- Allison Sabia, Vice President and General Manager, Digital, Arrow Electronics, Inc.
- Shawn Springs, CEO, Windpact
The full event, including TendoNova’s presentation, can be seen HERE on the NFL’s website.
TendoNova is currently in the development phase and expects to have products on the market and available to patients early next year.
About NFL 1st and Future
“1st and Future” is the NFL's annual Super Bowl competition designed to spur innovation in player health, safety, and performance. This year's event featured two categories of competition: NFL Punt Analytics Competition where applicants had access to NFL data sets to inform submissions about rule changes designed to reduce player injury during punt plays while maintaining the integrity of the game, and Innovations to Advance Athlete Health and Safety Competition: innovations that could improve player health and safety. To learn more, visit https://www.nfl.com/watch/event/firstandfuture.
About TendoNova
TendonNova is a medical device company whose flagship product is the Ocelot™ system, an integrated device and digital health solution that brings surgical-level care to the physician office. Designed to treat chronic tendon pains such as tennis elbow and plantar fasciitis, the Ocelot system was designed to lower both the recovery time and patient cost by bringing a proven treatment methodology into the physician office setting. To learn more, visit www.tendonova.com.